<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34698190</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2036-7430</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Infectious disease reports</Title><ISOAbbreviation>Infect Dis Rep</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls.</ArticleTitle><Pagination><StartPage>910</StartPage><EndPage>916</EndPage><MedlinePgn>910-916</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/idr13040082</ELocationID><Abstract><AbstractText>The primary aim of this study was to determine the seroprevalence of SARS-CoV-2 antibodies in a population of pediatric healthcare workers (HCWs). This study was conducted 14 May-13 July 2020. Study participants included pediatric HCWs at a pediatric hospital with either direct patient contact or close proximity to patient-care areas. SARS-CoV-2 antibodies were assessed via the Wytcote Superbio SARS-CoV-2 IgM/IgG Antibody Fast Detection Kit and the Abbott Architect SARS-CoV-2 IgG assay. Participants underwent RT-PCR testing upon entry to the study and following rapid IgM+/IgG+ results; respiratory panel PCR (RP-PCR) was performed following IgM+ results. A total of 57 of 289 (19.7%) of participants demonstrated positive serology as assessed by the Wytcote rapid kit (12 on Day 1 and 45 throughout the study). However, only one of these participants demonstrated IgG+ serology via the Abbott assay. Two participants tested SARS-CoV-2+ via RT-PCR testing. One individual was adenovirus+ and enterovirus/rhinovirus+. In our study population, we observed a seroprevalence of SARS-CoV-2 antibodies of 0.35%. The lack of concordance between antibody tests suggests that the Wytcote rapid test kit may not be of use as a screening tool. However, the feasibility of the overall process indicates that a similar methodology may have potential for future epidemiologic surveillance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heyming</LastName><ForeName>Theodore</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Children's Hospital of Orange County, Orange, CA 92868, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of California, Irvine, CA 92868, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Kellie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Hospital of Orange County, Orange, CA 92868, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Children's Hospital of Orange County, Orange, CA 92868, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knudsen-Robbins</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tongol</LastName><ForeName>Aprille</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospital of Orange County, Orange, CA 92868, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanger</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Children's Hospital of Orange County, Orange, CA 92868, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Electrical Engineering and Computer Science, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Infect Dis Rep</MedlineTA><NlmUniqueID>101537203</NlmUniqueID><ISSNLinking>2036-7430</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibody testing</Keyword><Keyword MajorTopicYN="N">pediatric healthcare workers</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>9</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34698190</ArticleId><ArticleId IdType="pmc">PMC8544562</ArticleId><ArticleId IdType="doi">10.3390/idr13040082</ArticleId><ArticleId IdType="pii">idr13040082</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Research Center  Published 2021.  [(accessed on 10 January 2021)].  Available online:  https://coronavirus.jhu.edu/</Citation></Reference><Reference><Citation>F&#xf8;ns S., Krogfelt K.A. How can we interpret SARS-CoV-2 antibody test results? Pathog. Dis. 2021;79 doi: 10.1093/femspd/ftaa069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftaa069</ArticleId><ArticleId IdType="pmc">PMC7858042</ArticleId><ArticleId IdType="pubmed">33512464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch K.L., Whitman J.D., Lacanienta N.P., Beckerdite E.W., Kastner S.A., Shy B.R., Goldgof G.M., Levine A.G., Bapat S.P., Stramer S.L., et al. Magnitude and kinetics of anti-severe acute respiratory syndrome Coronavirus 2 antibody responses and their relationship to disease severity. Clin. Infect. Dis. 2021;72:301&#x2013;308. doi: 10.1093/cid/ciaa979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa979</ArticleId><ArticleId IdType="pmc">PMC7454426</ArticleId><ArticleId IdType="pubmed">33501951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson L., McLawhon R.W., Kurian S., Fitzgerald R.L., Case J., Marsh C., Quigley M. Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego. Am. J. Infect. Control. 2021;49:506&#x2013;507. doi: 10.1016/j.ajic.2020.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2020.12.017</ArticleId><ArticleId IdType="pmc">PMC7836216</ArticleId><ArticleId IdType="pubmed">33388312</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt D., Johnson M., Falup-Pecurariu O., Ivaskeviciene I., Spoulou V., Tamm E., Wagner M., Zar H.J., Bleotu L., Ivaskevicius R., et al. Cross-Sectional Prevalence of SARS-CoV-2 Antibodies in healthcare workers in paediatric facilities in eight countries. J. Hosp. Infect. 2021;110:60&#x2013;66. doi: 10.1016/j.jhin.2020.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.12.019</ArticleId><ArticleId IdType="pmc">PMC7836791</ArticleId><ArticleId IdType="pubmed">33422589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuckerman J., Lee L.-Y., Wurzel D., Tosif S., Clifford V., McMinn A., O&#x2019;Donaghue K., Rautenbacher K., Licciardi P.V., Toh R., et al. Seroprevalence of SARS-CoV-2 Antibodies in health-care workers at a tertiary paediatric hospital. J. Paediatr. Child. Health. 2021;57:1136&#x2013;1139. doi: 10.1111/jpc.15585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.15585</ArticleId><ArticleId IdType="pmc">PMC8447152</ArticleId><ArticleId IdType="pubmed">34216170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsi E.-B., Dellis C., Petridou E., Banou K., Zachariadou L., Syriopoulou V., Michos A. SARS-CoV-2 Seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods. Infection. 2021:1&#x2013;6. doi: 10.1007/s15010-021-01653-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01653-2</ArticleId><ArticleId IdType="pmc">PMC8256773</ArticleId><ArticleId IdType="pubmed">34224078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasztelewicz B., Janiszewska K., Burzy&#x144;ska J., Szyd&#x142;owska E., Migda&#x142; M., Dzier&#x17c;anowska-Fangrat K. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland. PLoS ONE. 2021;16:e0249550. doi: 10.1371/journal.pone.0249550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249550</ArticleId><ArticleId IdType="pmc">PMC8016271</ArticleId><ArticleId IdType="pubmed">33793673</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhusudan M., Sankar J., Dhanalakshmi K., Putlibai S., Balasubramanian S. Seroprevalence to SARS-CoV-2 Among healthcare workers in an exclusive pediatric hospital. Indian Pediatr. 2021;58:279&#x2013;280. doi: 10.1007/s13312-021-2170-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-021-2170-1</ArticleId><ArticleId IdType="pmc">PMC8005282</ArticleId><ArticleId IdType="pubmed">33713065</ArticleId></ArticleIdList></Reference><Reference><Citation>Brant-Zawadzki M., Fridman D., Robinson P.A., Zahn M., Chau C., German R., Breit M., Bock J.R., Hara J. SARS-CoV-2 Antibody prevalence in health care workers: Preliminary report of a single center study. PLoS ONE. 2020;15:e0240006. doi: 10.1371/journal.pone.0240006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240006</ArticleId><ArticleId IdType="pmc">PMC7660494</ArticleId><ArticleId IdType="pubmed">33180782</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Case Counts and Testing Figures. OC Healthcare Agency. Published 2021.  [(accessed on 10 January 2021)].  Available online:  https://occovid19.ochealthinfo.com/coronavirus-in-oc.</Citation></Reference><Reference><Citation>Laursen J., Petersen J., Didriksen M., Iversen K., Ullum H. Prevalence of SARS-CoV-2 IgG/IgM antibodies among danish and swedish falck emergency and non-emergency healthcare workers. Int. J. Environ. Res. Public Health. 2021;18:923. doi: 10.3390/ijerph18030923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18030923</ArticleId><ArticleId IdType="pmc">PMC7908436</ArticleId><ArticleId IdType="pubmed">33494409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebinger J.E., Botwin G.J., Albert C.M., Alotaibi M., Arditi M., Berg A.H., Binek A., Botting P., Fert-Bober J., Figueiredo J.C., et al. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: A cross-sectional study. BMJ Open. 2021;11:e043584. doi: 10.1136/bmjopen-2020-043584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043584</ArticleId><ArticleId IdType="pmc">PMC7883610</ArticleId><ArticleId IdType="pubmed">33579769</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.N., Altawallbeh G., Zaun C.P., Pape K.A., Peters J.M., Titcombe P.J., Dileepan T., Rapp M.J., Bold T.D., Schacker T.W., et al. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA. Clin. Biochem. 2021;90:15&#x2013;22. doi: 10.1016/j.clinbiochem.2021.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2021.01.010</ArticleId><ArticleId IdType="pmc">PMC7849522</ArticleId><ArticleId IdType="pubmed">33539808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour M., Leven E., Muellers K., Stone K., Mendu D.R., Wajnberg A. Prevalence of SARS-CoV-2 antibodies among healthcare workers at a tertiary academic hospital in New York City. J. Gen. Intern. Med. 2020;35:2485&#x2013;2486. doi: 10.1007/s11606-020-05926-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05926-8</ArticleId><ArticleId IdType="pmc">PMC7269421</ArticleId><ArticleId IdType="pubmed">32495088</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensels D., Oris E., Coninx L., Nuyens D., Delforge M.-L., Vermeersch P., Heylen L. Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium. JAMA. 2020;324:195&#x2013;197. doi: 10.1001/jama.2020.11160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.11160</ArticleId><ArticleId IdType="pmc">PMC7296458</ArticleId><ArticleId IdType="pubmed">32539107</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Sun J., Nie S., Li H., Kong Y., Liang M., Hou J., Huang X., Li D., Ma T., et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat. Med. 2020;26:1193&#x2013;1195. doi: 10.1038/s41591-020-0949-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0949-6</ArticleId><ArticleId IdType="pubmed">32504052</ArticleId></ArticleIdList></Reference><Reference><Citation>Korth J., Wilde B., Dolff S., Anastasiou O.E., Krawczyk A., Jahn M., Cordes S., Ross B., Esser S., Lindemann M., et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J. Clin. Virol. 2020;128:104437. doi: 10.1016/j.jcv.2020.104437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104437</ArticleId><ArticleId IdType="pmc">PMC7219425</ArticleId><ArticleId IdType="pubmed">32434708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ins&#xfa;a C., Stedile G., Figueroa V., Hern&#xe1;ndez C., Svartz A., Ferrero F., Ossorio M.F., Brunetto O. Seroprevalence of SARS-CoV-2 antibodies among physicians from a children&#x2019;s hospital. Arch. Argent. Pediatr. 2020;118:381&#x2013;385. doi: 10.5546/aap.2020.eng.381.</Citation><ArticleIdList><ArticleId IdType="doi">10.5546/aap.2020.eng.381</ArticleId><ArticleId IdType="pubmed">33231044</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola A., Tanzi E., Folgori L., Barcellini L., Bianchi S., Gori M., Cammi G., Albani E., Zuccotti G.V. Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave. Infect. Control Hosp. Epidemiol. 2020;41:1468&#x2013;1469. doi: 10.1017/ice.2020.401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.401</ArticleId><ArticleId IdType="pmc">PMC7438626</ArticleId><ArticleId IdType="pubmed">32758311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dacosta-Urbieta A., Rivero-Calle I., Pardo-Seco J., Redondo-Collazo L., Salas A., G&#xf3;mez-Rial J., Martin&#xf3;n-Torres F. Seroprevalence of SARS-CoV-2 among pediatric healthcare workers in Spain. Front. Pediatr. 2020;8:547. doi: 10.3389/fped.2020.00547.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00547</ArticleId><ArticleId IdType="pmc">PMC7516980</ArticleId><ArticleId IdType="pubmed">33042908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan A., Pepper G., Wener M.H., Fink S.L., Morishima C., Chaudhary A., Jerome K.R., Mathias P.C., Greninger A.L. Performance characteristics of the abbott architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J. Clin. Microbiol. 2020;58:e00941-20. doi: 10.1128/JCM.00941-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00941-20</ArticleId><ArticleId IdType="pmc">PMC7383515</ArticleId><ArticleId IdType="pubmed">32381641</ArticleId></ArticleIdList></Reference><Reference><Citation>Manalac J., Yee J., Calayag K., Nguyen L., Patel P.M., Zhou D., Shi R.-Z. Evaluation of Abbott Anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab. Clin. Chim. Acta. 2020;510:687&#x2013;690. doi: 10.1016/j.cca.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7476889</ArticleId><ArticleId IdType="pubmed">32910980</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q.-X., Liu B.-Z., Deng H.-J., Wu G.-C., Deng K., Chen Y.-K., Liao P., Qiu J.-F., Lin Y., Cai X.-F., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 2020;26:845&#x2013;848. doi: 10.1038/s41591-020-0897-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0897-1</ArticleId><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Najm A., Alunno A., Mariette X., Terrier B., De Marco G., Emmel J., Mason L., McGonagle D.G., Machado P.M. Pathophysiology of acute respiratory syndrome Coronavirus 2 infection: A systematic literature review to Inform EULAR points to consider. RMD Open. 2021;7:e001549. doi: 10.1136/rmdopen-2020-001549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2020-001549</ArticleId><ArticleId IdType="pmc">PMC7880117</ArticleId><ArticleId IdType="pubmed">33574116</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D., Egli-Gany D., Counotte M.J., Hossmann S., Imeri H., Ipekci A.M., Salanti G., Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and Meta-analysis. PLoS Med. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003346</ArticleId><ArticleId IdType="pmc">PMC7508369</ArticleId><ArticleId IdType="pubmed">32960881</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa K., Arii J., Nishimura M., Tjan L.H., Lystia Poetranto A., Ren Z., Aktar S., Huang J.R., Sutandhio S., Kurahashi Y., et al. Seroepidemiological survey of the antibody for severe acute respiratory syndrome Coronavirus 2 with neutralizing activity at hospitals: A cross-sectional study in Hyogo Prefecture, Japan. JMAJ. 2021;4:41&#x2013;49. doi: 10.31662/jmaj.2020-0094.</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2020-0094</ArticleId><ArticleId IdType="pmc">PMC7872787</ArticleId><ArticleId IdType="pubmed">33575502</ArticleId></ArticleIdList></Reference><Reference><Citation>Poll&#xe1;n M., P&#xe9;rez-G&#xf3;mez B., Pastor-Barriuso R., Oteo J., Hern&#xe1;n M.A., P&#xe9;rez-Olmeda M., Sanmart&#xed;n J.L., Fern&#xe1;ndez-Garc&#xed;a A., Cruz I., Fern&#xe1;ndez de Larrea N., et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): A nationwide, population-based seroepidemiological study. Lancet. 2020;396:535&#x2013;544. doi: 10.1016/S0140-6736(20)31483-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31483-5</ArticleId><ArticleId IdType="pmc">PMC7336131</ArticleId><ArticleId IdType="pubmed">32645347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalish H., Klumpp-Thomas C., Hunsberger S., Baus H.A., Fay M.P., Siripong N., Wang J., Hicks J., Mehalko J., Travers J., et al. Mapping a pandemic: SARS-CoV-2 seropositivity in the United States. medRxiv. 2021 doi: 10.1101/2021.01.27.21250570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250570</ArticleId><ArticleId IdType="pmc">PMC8432952</ArticleId><ArticleId IdType="pubmed">34158410</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelzang E.H., Loeff F.C., Derksen N.I.L., Kruithof S., Ooijevaar-de Heer P., van Mierlo G., Linty F., Mok J.Y., van Esch W., de Bruin S., et al. Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and nonhospitalized patients with COVID-19. J. Immunol. 2020;205:3491&#x2013;3499. doi: 10.4049/jimmunol.2000767.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000767</ArticleId><ArticleId IdType="pubmed">33127820</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradenas E., Trinit&#xe9; B., Urrea V., Marfil S., &#xc1;vila-Nieto C., de la Concepci&#xf3;n M.L.R., Tarr&#xe9;s-Freixas F., P&#xe9;rez-Yanes S., Rovirosa C., Ainsua-Enrich E., et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Medcine. 2021;2:313.e4&#x2013;320.e4. doi: 10.1016/j.medj.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7847406</ArticleId><ArticleId IdType="pubmed">33554155</ArticleId></ArticleIdList></Reference><Reference><Citation>Marot S., Malet I., Leducq V., Zafilaza K., Sterlin D., Planas D., Gothland A., Jary A., Dorgham K., Bruel T., et al. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat. Commun. 2021;12:844. doi: 10.1038/s41467-021-21111-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21111-9</ArticleId><ArticleId IdType="pmc">PMC7870823</ArticleId><ArticleId IdType="pubmed">33558507</ArticleId></ArticleIdList></Reference><Reference><Citation>Seow J., Graham C., Merrick B., Acors S., Pickering S., Steel K.J.A., Hemmings O., O&#x2019;Byrne A., Kouphou N., Galao R.P., et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat. Microbiol. 2020;5:1598&#x2013;1607. doi: 10.1038/s41564-020-00813-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00813-8</ArticleId><ArticleId IdType="pmc">PMC7610833</ArticleId><ArticleId IdType="pubmed">33106674</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007;357:1903&#x2013;1915. doi: 10.1056/NEJMoa066092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa066092</ArticleId><ArticleId IdType="pubmed">17989383</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel D.A., Reses H.E., Cool A.J., Shapiro C.N., Hsu J., Boehmer T.K., Cornwell C.R., Gray E.B., Henley S.J., Lochner K., et al. Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0-17 years&#x2014;United States, August 2020&#x2013;August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1249&#x2013;1254. doi: 10.15585/mmwr.mm7036e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036e1</ArticleId><ArticleId IdType="pmc">PMC8437056</ArticleId><ArticleId IdType="pubmed">34499628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.E., Caliendo A.M., Arias C.A., Englund J.A., Hayden M.K., Lee M.J., Loeb M., Patel R., Altayar O., El Alayli A., et al.  Guidelines on the Diagnosis of COVID-19: Serologic Testing. Infectious Diseases Society of America. 2020.  [(accessed on 10 January 2021)].  Available online:  https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543294</ArticleId><ArticleId IdType="pubmed">32918466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>